checkAd

    EQS-Adhoc  862  0 Kommentare HOCHDORF Holding Ltd: Signing of agreement and extraordinary General Meeting

    EQS Group-Ad-hoc: HOCHDORF Holding AG / Key word(s): Takeover/AGM/EGM
    HOCHDORF Holding Ltd: Signing of agreement and extraordinary General Meeting

    25.10.2016 / 07:00
    Release of an ad hoc announcement pursuant to Art. 53 KR.


    ---------------------------------------------------------------------------

    HOCHDORF Group Press Release: Signing of agreement / Extraordinary General
    Meeting


    HOCHDORF signs agreement on majority holding of Pharmalys Laboratories SA

    Hochdorf, 24 October 2016 - The HOCHDORF Group has signed the purchase
    agreement to acquire 51% of Pharmalys Laboratories SA, 51% of Pharmalys
    Tunisia Ltd SA and 51% of Pharmalys Africa Sarl, which is to be founded
    jointly. The agreement takes the HOCHDORF Group a significant step towards
    the end consumer in the Baby Care business area. The acquisition is
    expected to be completed by the end of 2016.

    The HOCHDORF Group has been producing infant formula since 1908, primarily
    for the Swiss market up to 2006, when HOCHDORF launched its successful
    internationalisation project. To date, however, the company has not been
    active on the end-consumer market. This will change with a 51% majority
    holding in Pharmalys Laboratories SA, Pharmalys Tunisia SA and Pharmalys
    Africa Sarl.

    Historic step for the HOCHDORF Group
    "By signing this agreement, we have met the legal objectives of the
    statement of intent," said a delighted HOCHDORF CEO, Dr Thomas Eisenring.
    Chairman of the Board of Directors, Josef Leu, explained: "This majority
    shareholding represents a historic step for the HOCHDORF Group - a step
    towards the end consumer." Amir Mechria, appointed CEO of Pharmalys, also
    spoke in terms of a huge development for Pharmalys: "This mutual
    shareholding allows Pharmalys to gain access to high-value Swiss products."
    Leu, Eisenring and Mechria all emphasised how the planned Kid's Food
    products will add great value to the close collaboration.

    The acquisition of the shareholding is expected to be completed by the end
    of 2016.

    Extraordinary General Meeting
    HOCHDORF has been supplying the Pharmalys Group with infant formula since
    2008. A close collaboration has developed over this period, with Pharmalys
    becoming one of HOCHDORF's biggest customers in the area of Baby Care. No
    significant changes are anticipated in the cooperation with the Pharmalys
    team. Amir Mechria is therefore also interested in HOCHDORF Holding Ltd
    shares and a share exchange. In order to be able to complete the majority
    shareholding, the HOCHDORF Holding Ltd Board of Directors is requesting a
    conditional capital increase to a maximum amount of 717,380 fully paid-in
    registered shares with a nominal value of CHF 10 and an increase to the
    Seite 1 von 2


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc HOCHDORF Holding Ltd: Signing of agreement and extraordinary General Meeting EQS Group-Ad-hoc: HOCHDORF Holding AG / Key word(s): Takeover/AGM/EGM HOCHDORF Holding Ltd: Signing of agreement and extraordinary General Meeting 25.10.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. …